Reply to DiNubile.
Publication
, Journal Article
Corey, GR; Boucher, HW; Stryjewski, ME
Published in: Clin Infect Dis
April 15, 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
April 15, 2015
Volume
60
Issue
8
Start / End Page
1291 / 1292
Location
United States
Related Subject Headings
- Vancomycin
- Staphylococcal Infections
- Skin Diseases, Bacterial
- Microbiology
- Methicillin Resistance
- Male
- Humans
- Glycopeptides
- Female
- Cefazolin
Citation
APA
Chicago
ICMJE
MLA
NLM
Corey, G. R., Boucher, H. W., & Stryjewski, M. E. (2015). Reply to DiNubile. Clin Infect Dis, 60(8), 1291–1292. https://doi.org/10.1093/cid/civ025
Corey, G Ralph, Helen W. Boucher, and Martin E. Stryjewski. “Reply to DiNubile.” Clin Infect Dis 60, no. 8 (April 15, 2015): 1291–92. https://doi.org/10.1093/cid/civ025.
Corey GR, Boucher HW, Stryjewski ME. Reply to DiNubile. Clin Infect Dis. 2015 Apr 15;60(8):1291–2.
Corey, G. Ralph, et al. “Reply to DiNubile.” Clin Infect Dis, vol. 60, no. 8, Apr. 2015, pp. 1291–92. Pubmed, doi:10.1093/cid/civ025.
Corey GR, Boucher HW, Stryjewski ME. Reply to DiNubile. Clin Infect Dis. 2015 Apr 15;60(8):1291–1292.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
April 15, 2015
Volume
60
Issue
8
Start / End Page
1291 / 1292
Location
United States
Related Subject Headings
- Vancomycin
- Staphylococcal Infections
- Skin Diseases, Bacterial
- Microbiology
- Methicillin Resistance
- Male
- Humans
- Glycopeptides
- Female
- Cefazolin